Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mahmoud H, Zahran"'
Autor:
Sawsan Fadda, Eman H. Abd Elbary, Mahmoud H Zahran, Ali M Shendi, Walid Ahmed Ragab Abdelhamid
Publikováno v:
Brazilian Journal of Nephrology (2021)
Brazilian Journal of Nephrology n.ahead 2021
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology v.44 n.2 2022
Brazilian Journal of Nephrology, Issue: ahead, Published: 12 FEB 2021
Brazilian Journal of Nephrology n.ahead 2021
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology v.44 n.2 2022
Brazilian Journal of Nephrology, Issue: ahead, Published: 12 FEB 2021
Membranoproliferative glomerulonephritis (MPGN) is the most typical Hepatitis C virus (HCV)-associated glomerulopathy, and the available data about the utilization of direct-acting antivirals (DAA) in HCV-associated glomerulonephritis is inadequate.
Autor:
Mohamed Salah El Din Zaki, Mahmoud Maamoun Amin Maamoun, Amir Mohamed El Okely, Mahmoud H Zahran
Publikováno v:
The Egyptian Journal of Hospital Medicine. 80:553-595
Background: Long-term outcome in renal transplantation is heterogeneous, and predicting success is challenging. Serum β2-microglobulin (β2MG), a novel marker of kidney function, predicts mortality and kidney failure in the general population, and i
Publikováno v:
Hemodialysis international. International Symposium on Home HemodialysisREFERENCES. 26(2)
Parathormone (PTH) and phosphorus, which are considered as uremic toxins, are associated with reduced red cell survival, yet with unproven mechanism. We aimed to assess the relation between PTH and phosphorus levels and eryptosis in patients with CKD
Autor:
Hany M Elsadek, Islam A. Elsayed, Ayman M. Zaki, Mahmoud H Zahran, Hussien Ahmed, Mohamed Gendia, Monkez M Yousif, Hamdy Shafeik, Mahmoud Magdy, Nevin F. lbrahim, Ayman M. E. M. Sadek, Ali M Shendi, Tamer M. Gouda
Publikováno v:
Journal of viral hepatitisREFERENCES. 27(11)
The aim of this study was to assess the efficacy and safety of two protocols for retreatment of a cohort of Egyptian patients with chronic hepatitis C (CHC) who relapsed after NS5A inhibitor-based therapy. We conducted a prospective cohort study to a
Autor:
Amir M Elokely, Ahmed Yahia Elmowafy, Essam Elsawy, Tamer M. Gouda, Hazem Hamed Saleh, Mahmoud H Zahran, Ahmed M. Abdel-Rahman, Ehab W. Wafa, Mohamed Kamal Ahmed Ibrahim
Publikováno v:
Journal of The Egyptian Society of Nephrology and Transplantation. 21:65
Background Variable prophylaxis regimens have been adapted to guard against cytomegalovirus (CMV) after renal transplantation. High-dose valganciclovir (VGCV) is the gold standard, but it is of very high cost. Herein, we compared another low-cost reg
Autor:
Monkez M, Yousif, Ahmed, Elsadek Fakhr, Emad A, Morad, Hesham, Kelani, Emad F, Hamed, Hany M, Elsadek, Mahmoud H, Zahran, Afify, Fahmy Afify, Waleed A, Ismail, Ahmed I, Elagrody, Nevin F, Ibrahim, Fatma A, Amer, Ayman M, Zaki, Ayman M E M, Sadek, Ali M, Shendi, George, Emad, Hesham A, Farrag
Publikováno v:
Le infezioni in medicina. 26(3)
The reappearance of HCV infection months or years after sustained virologic response (SVR) may be due to the persistence of HCV in tissue cells in spite of being undetected in serum. This situation is known as occult hepatitis C infection (OCI). We a
Publikováno v:
Nephrology Dialysis Transplantation. 33:i405-i405